Pfizer Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 29, 2025: USD 6.89 B

Pfizer Inc. Depreciation And Amortization is USD 6.89 B for the Trailing 12 Months (TTM) ending March 29, 2025, a 5.44% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Pfizer Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 6.54 B, a 21.91% change year over year.
  • Pfizer Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending April 02, 2023 was USD 5.36 B, a 4.11% change year over year.
  • Pfizer Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending April 03, 2022 was USD 5.15 B, a 7.67% change year over year.
  • Pfizer Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending April 04, 2021 was USD 4.79 B, a -15.80% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased